CENTRAL TRUST Co Cuts Stake in Colgate-Palmolive (NYSE:CL)

CENTRAL TRUST Co cut its holdings in Colgate-Palmolive (NYSE:CL) by 1.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 28,835 shares of the company’s stock after selling 369 shares during the quarter. CENTRAL TRUST Co’s holdings in Colgate-Palmolive were worth $2,621,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CL. Peak Financial Advisors LLC purchased a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $1,315,000. Gordian Advisors LLC purchased a new stake in Colgate-Palmolive during the third quarter worth $602,000. Carrera Capital Advisors increased its holdings in shares of Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after acquiring an additional 7,353 shares during the period. Fiduciary Alliance LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter worth $4,066,000. Finally, Vontobel Holding Ltd. lifted its stake in shares of Colgate-Palmolive by 224.6% during the 3rd quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after purchasing an additional 550,750 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Down 4.7 %

NYSE:CL opened at $86.64 on Monday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The company’s fifty day moving average price is $91.35 and its 200-day moving average price is $97.17. Colgate-Palmolive has a 1-year low of $82.68 and a 1-year high of $109.30. The firm has a market capitalization of $70.78 billion, a P/E ratio of 24.82, a PEG ratio of 3.70 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 405.81% and a net margin of 14.27%. During the same quarter in the prior year, the company posted $0.87 EPS. As a group, equities research analysts anticipate that Colgate-Palmolive will post 3.58 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.31%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Analyst Upgrades and Downgrades

CL has been the subject of a number of recent research reports. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. JPMorgan Chase & Co. decreased their target price on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research report on Thursday, January 16th. TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Finally, UBS Group lowered their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $102.00.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.